Characteristics of the endocrine system during pregnancy
Physiological reorganization of a woman's body during gestation inevitably affects the functioning of endocrine organs. Changes in the levels of sex hormones and metabolic processes place an additional burden on the thyroid gland. During pregnancy, even minor deviations in the synthesis of thyroid hormones can lead to a breakdown of adaptation mechanisms, which requires dynamic monitoring of the patient's condition.
Impact on the course of pregnancy
Thyroid pathology, like other endocrine disorders (for example, diabetes mellitus), can provoke a number of serious complications:
- Threat of miscarriage and pregnancy loss.
- Development of placental insufficiency.
- Risk of fetal malformations.
- Fetal growth restriction and hypoxic states.
Diagnosis and management tactics
The key management principle is early detection of disorders. The diagnostic algorithm includes hormone level assessment and clinical observation. The primary objective of the physician is the timely correction of thyroid function, which minimizes risks for the mother and ensures normal fetal development. If endocrine pathology is suspected, consultation with a subspecialist is necessary to select appropriate therapy.
Briefly: answers to topical questions
Which specific hormones and antibodies are included in the laboratory screening of thyroid function in pregnant women?
Laboratory screening of thyroid function in pregnant women includes thyroid-stimulating hormone (TSH) and thyroid peroxidase antibodies (anti-TPO). The test is performed once at the first prenatal visit or at the preconception stage when planning a pregnancy.
When TSH > 2.5 IU/ml and anti-TPO are present (+), or when TSH > 4.0 IU/ml regardless of anti-TPO presence, a consultation with an endocrinologist is indicated to prescribe hypothyroidism therapy.
How does the physiological increase in hCG levels affect the production of TSH and free T4 in the first trimester?
The physiological increase in human chorionic gonadotropin levels leads to a transient suppression of TSH levels combined with an elevated free thyroxine level. This process is characteristic of the first half of pregnancy and is due to the structural homology of TSH and hCG. Human chorionic gonadotropin, secreted by the placenta, exerts a thyrotropic effect on the thyroid gland, causing transient gestational hyperthyroidism. This condition is physiological, requires no specific therapy, and resolves completely by the 16th–20th week of gestation.
Which drug is used and according to what principles is it dosed for hormone replacement therapy of hypothyroidism in pregnant women?
Levothyroxine sodium is used for hormone replacement therapy of hypothyroidism in pregnant women. The main dosing principle is that upon diagnosing hypothyroidism during pregnancy, a full replacement dose of the drug must be prescribed immediately. Levothyroxine sodium has no teratogenic effect on the fetus. Mandatory replacement therapy is indicated for both overt and subclinical hypothyroidism, as the normalization of TSH levels reduces the risk of premature termination of pregnancy to general population levels.
Which antithyroid drugs are the drugs of choice for treating thyrotoxicosis in the first and subsequent trimesters?
The drug of choice for treating thyrotoxicosis (Graves' disease) in pregnant women is propylthiouracil. Sources do not distinguish different drugs of choice for the first and subsequent trimesters, but indicate that after the 1st trimester, symptoms become less pronounced. This allows the dose of antithyroid drugs in the 2nd and 3rd trimesters to be reduced to the minimum maintenance dose. Thiouracil-group antithyroid drugs are prescribed in relatively small doses due to the risk of congenital colloid goiter in the fetus.
How does the management strategy for pregnant women with Graves' disease differ from that for patients with gestational transient thyrotoxicosis?
The management strategy for patients with these conditions differs radically in the necessity of medical treatment.
| Condition | Management tactics |
|---|---|
| Graves' disease | Carried out jointly with an endocrinologist. The main method is antithyroid therapy (drug of choice is propylthiouracil). The dose is reduced in the 2nd–3rd trimesters to the minimum maintenance dose. |
| Transient gestational hyperthyroidism | Requires no specific therapy. The condition is physiological and resolves completely on its own by the 16th–20th week of pregnancy. |
How does the level of thyroxine-binding globulin (TBG) change during pregnancy and how does this affect total T4 levels?
During pregnancy, the level of thyroxine-binding globulin increases due to enhanced synthesis in the liver under the influence of placental estrogens. Consequently, the bound fractions of thyroxine and triiodothyronine increase compensatorily, reaching a maximum by the 20th–22nd week of pregnancy. The levels of free thyroxine and triiodothyronine fractions remain relatively stable in the 2nd and 3rd trimesters.
THY: Thyroid gland, Individual control, Therapy is the key to maternal and fetal health.
Class and exam questions
Why are thyroid diseases dangerous during pregnancy?
They increase the risk of miscarriage and placental insufficiency, and can negatively affect fetal development due to hormonal imbalance.
How often should thyroid function be monitored?
The frequency of monitoring is determined individually, based on the severity of the condition and the dynamics of parameters, to maintain a stable euthyroid state.
What is the main goal of treatment?
The goal is to achieve and maintain normal hormone levels, which prevents pregnancy complications and ensures normal intrauterine development.
What else to study on this topic
- Differential diagnosis of thyrotoxicosis and physiological changes during pregnancy.
- The impact of iodine deficiency on thyroid function in pregnant women.
- Algorithms for drug dosage selection in hypothyroidism.
- Peculiarities of labor management in patients with endocrine pathology.
- Monitoring of fetal condition in maternal thyroid disorders.
Master the entire topic in the "Obstetrics and Gynecology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thyroid diseases during pregnancy" and 973 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 21 video lessons on the subject
Other topics in the "Obstetrics" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.